Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
DisGeNET
DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
| Source | Last Updated |
|---|---|
| DisGeNET | July 29, 2024 |
| Disease ID | Disease Name | Gene Symbol ▼ | Gene ID | Gene Name | UniProt ID |
|---|---|---|---|---|---|
| C0740391 | Middle Cerebral Artery Occlusion | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C1263846 | Attention deficit hyperactivity disorder | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0751364 | Cancer, Embryonal | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0027654 | Embryonal Neoplasm | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0017638 | Glioma | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C1510586 | Autism Spectrum Disorders | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0162820 | Dermatitis, Allergic Contact | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0011849 | Diabetes Mellitus | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0278878 | Adult Glioblastoma | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0700095 | Central neuroblastoma | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0238463 | Papillary thyroid carcinoma | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0242379 | Malignant neoplasm of lung | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0027658 | Neoplasms, Germ Cell and Embryonal | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C1332206 | Adult Lymphoma | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0041296 | Tuberculosis | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0036341 | Schizophrenia | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0028754 | Obesity | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0023903 | Liver neoplasms | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0079731 | B-Cell Lymphomas | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0699885 | Carcinoma of bladder | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0205851 | Germ cell tumor | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0003873 | Rheumatoid Arthritis | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0007134 | Renal Cell Carcinoma | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0020456 | Hyperglycemia | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0014175 | Endometriosis | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
